#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12834	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2009	630.2	0	.	n	.	0	C451T	SNP	451	451	C	673	673	T	738	T,C	563,160	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12834	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2009	630.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	732	C,A	720,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3533	668.5	0	.	n	.	0	T695C	SNP	695	695	T	1062	1062	C	703	C,T	678,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3533	668.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2338	2338	C	746	C,T	727,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3533	668.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2412	2412	A	788	A	777	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3533	668.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2964	2964	C	750	C,T	737,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3533	668.5	0	HET	.	.	.	C539T	.	539	539	C	906	906	C	769	C,T	585,165	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	98	blaTEM	861	861	100.0	blaTEM.l15.c30.ctg.1	961	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1806	folP	855	855	100.0	folP.l15.c4.ctg.1	1484	120.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1004	1006	AGC	179;181;180	A;G;C	177;179;177	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4924	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	142.5	1	SNP	p	S91F	1	.	.	271	273	TTC	630	632	TTC	157;157;156	T;T;C	155;156;155	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4924	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	142.5	1	SNP	p	G95N	0	.	.	283	285	GGC	642	644	GGC	149;149;149	G;G;C	146;146;143	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4924	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3433	142.5	1	SNP	p	D95G	1	.	.	283	285	GGC	642	644	GGC	149;149;149	G;G;C	146;146;143	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1498	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1424	104.7	1	SNP	p	G45D	0	.	.	133	135	GGC	554	556	GGC	192;189;190	G;G;C	187;185;186	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	812	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	828	95.8	0	.	n	.	0	A197.	DEL	197	197	A	468	468	A	166	A	164	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	143.2	1	SNP	p	D86N	0	.	.	256	258	GAC	573	575	GAC	167;167;168	G;A;C,T	162;155;161,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	143.2	1	SNP	p	R87W	0	.	.	259	261	CGT	576	578	CGT	168;165;165	C;G;T	164;158;158	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	143.2	1	SNP	p	S87R	1	.	.	259	261	CGT	576	578	CGT	168;165;165	C;G;T	164;158;158	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	143.2	1	SNP	p	R87I	0	.	.	259	261	CGT	576	578	CGT	168;165;165	C;G;T	164;158;158	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4282	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2973	143.2	1	SNP	p	S88P	0	.	.	262	264	TCC	579	581	TCC	166;167;168	T;C,T;C	159;161,1;162	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3802	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2684	140.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1521	1523	GGC	190;187;181	G;G;C	184;181;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1246	1248	GCC	212;215;214	G;C;C	205;209;208	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1249	1251	ATG	213;215;213	A;T;G	207;209;207	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1261	1263	ACC	214;213;216	A;C;C	203;206;208	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1261	1263	ACC	214;213;216	A;C;C	203;206;208	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1762	1764	ACC	182;183;185	A;C;C	172;177;180	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1816	1818	GCG	168;168;168	G;C;G	164;163;164	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1816	1818	GCG	168;168;168	G;C;G	164;163;164	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1939	1941	GGT	137;136;133	G;G;T,C	135;134;128,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1948	1950	AGC	128;127;124	A,G;G;C,G	124,1;123;115,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2359	152.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1966	1968	CCG	93;91;91	C,G;C,G;G,T,C	83,1;79,2;73,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4936	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3092	158.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1642	1644	CCG	149;151;150	C;C;G,C	133;148;137,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2184	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1895	114.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	583	583	C	167	C,G	153,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	91	93	AAT	13;13;14	A;A;T	13;13;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	94	96	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	118	120	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	141	143	GTA	8;8;8	G;T;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	W235trunc	TRUNC	703	703	T	144	144	T	7	T	7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	240	porB1a	984	285	90.66	porB1a.l15.c17.ctg.2	351	18.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	150	150	A	6	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	990	992	AGA	221;221;219	A;G;A	217;215;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1011	1013	GGT	220;217;216	G;G;T	214;214;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1116	1118	GAA	176;176;178	G;A;A,C	175;175;176,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	1	SNP	p	G120K	1	.	.	358	360	AAG	720	722	AAG	193;197;199	A;A;G	188;192;193	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	1	SNP	p	N121D	0	.	.	361	363	AAC	723	725	AAC	199;199;197	A;A,G;C	196;192,1;191	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2616	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1595	162.2	1	SNP	p	A121N	1	.	.	361	363	AAC	723	725	AAC	199;199;197	A;A,G;C	196;192,1;191	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8784	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5003	174.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	936	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1010	92.0	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	187;187;190	A;T;G	185;186;188	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	176	99.43	tetM.l6.c4.ctg.1	217	1.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	18	20	GAA	1;1;1	G;A;A	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	M177T	NONSYN	529	531	ATG	43	45	ACG	2;2;2	A;C;G	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	64	66	GAC	3;3;3	G;A;C	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	T190M	NONSYN	568	570	ACG	82	84	ATG	3;3;3	A;T;G	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	L194S	NONSYN	580	582	TTA	94	96	TCA	3;3;3	T;C;A	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	139	141	CAA	1;1;1	C;A;A,G	1;1;0,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	V216L	NONSYN	646	648	GTT	160	162	CTT	2;1;1	C;T;T	2;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	N223S	NONSYN	667	669	AAC	181	183	AGT	2;2;2	A;G;T	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	18	tetM	1920	247	91.9	tetM.l6.c4.ctg.2	247	1.9	0	.	p	.	0	I225R	NONSYN	673	675	ATA	187	189	AGA	2;2;2	A;G,T;A	2;0,2;2	.	Tetracycline resistance
